JP2023528207A5 - - Google Patents
Info
- Publication number
- JP2023528207A5 JP2023528207A5 JP2022568692A JP2022568692A JP2023528207A5 JP 2023528207 A5 JP2023528207 A5 JP 2023528207A5 JP 2022568692 A JP2022568692 A JP 2022568692A JP 2022568692 A JP2022568692 A JP 2022568692A JP 2023528207 A5 JP2023528207 A5 JP 2023528207A5
- Authority
- JP
- Japan
- Prior art keywords
- ankyrin repeat
- binding protein
- amino acids
- repeat domain
- protein according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20174830 | 2020-05-14 | ||
| EP20174830.8 | 2020-05-14 | ||
| PCT/EP2021/062874 WO2021229076A1 (en) | 2020-05-14 | 2021-05-14 | Recombinant cd40 binding proteins and their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528207A JP2023528207A (ja) | 2023-07-04 |
| JP2023528207A5 true JP2023528207A5 (enExample) | 2024-05-09 |
Family
ID=70738293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568692A Pending JP2023528207A (ja) | 2020-05-14 | 2021-05-14 | 組換えｃｄ４０結合タンパク質及びそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240279309A1 (enExample) |
| EP (1) | EP4149960A1 (enExample) |
| JP (1) | JP2023528207A (enExample) |
| CN (1) | CN115996945A (enExample) |
| AU (1) | AU2021271131A1 (enExample) |
| CA (1) | CA3178478A1 (enExample) |
| WO (1) | WO2021229076A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020402581A1 (en) | 2019-12-11 | 2022-06-23 | Molecular Partners Ag | Designed ankyrin repeat domains with altered surface residues |
| IL298168A (en) | 2020-05-14 | 2023-01-01 | Molecular Partners Ag | Multispecific proteins |
| US11981710B2 (en) | 2020-08-18 | 2024-05-14 | Athebio Ag | N-terminal capping modules of ankyrin repeat domains |
| EP3957649A1 (en) | 2020-08-18 | 2022-02-23 | Athebio AG | Improved n-terminal capping modules of ankyrin repeat domains |
| WO2022190016A1 (en) | 2021-03-09 | 2022-09-15 | Molecular Partners Ag | Novel darpin based multi-specific t-cell engagers |
| WO2023021050A1 (en) * | 2021-08-17 | 2023-02-23 | Athebio Ag | Variants of ankyrin repeat domains |
| EP4137508A1 (en) * | 2021-08-17 | 2023-02-22 | Athebio AG | Variants of ankyrin repeat domains |
| EP4724473A1 (en) * | 2023-06-06 | 2026-04-15 | Molecular Partners AG | Recombinant cd47 binding proteins and their use |
| WO2025146490A1 (en) * | 2024-01-05 | 2025-07-10 | Molecular Partners Ag | Recombinant cd117 binding proteins and their use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1332209B1 (en) | 2000-09-08 | 2009-11-11 | Universität Zürich | Collections of repeat proteins comprising repeat modules |
| AR039067A1 (es) | 2001-11-09 | 2005-02-09 | Pfizer Prod Inc | Anticuerpos para cd40 |
| CA2700391A1 (en) | 2007-09-24 | 2009-04-02 | University Of Zuerich | Designed armadillo repeat proteins |
| WO2011040972A1 (en) | 2009-10-02 | 2011-04-07 | Ludwig Institute For Cancer Research Ltd. | Anti-fibroblast activation protein antibodies and methods and uses thereof |
| EP3514169B1 (en) * | 2010-11-26 | 2024-03-06 | Molecular Partners AG | Designed repeat proteins binding to serum albumin |
| EP2738180A1 (en) * | 2012-11-30 | 2014-06-04 | Molecular Partners AG | Binding proteins comprising at least two binding domains against HER2. |
| US11453708B2 (en) * | 2013-05-31 | 2022-09-27 | Molecular Partners Ag | Designed ankyrin repeat proteins binding to hepatocyte growth factor |
| US9458211B1 (en) * | 2015-04-02 | 2016-10-04 | Molecular Partners Ag | Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains |
| MY196882A (en) * | 2016-09-22 | 2023-05-08 | Molecular Partners Ag | Recombinant binding proteins and their use |
-
2021
- 2021-05-14 AU AU2021271131A patent/AU2021271131A1/en active Pending
- 2021-05-14 CN CN202180045415.9A patent/CN115996945A/zh active Pending
- 2021-05-14 EP EP21725188.3A patent/EP4149960A1/en active Pending
- 2021-05-14 CA CA3178478A patent/CA3178478A1/en active Pending
- 2021-05-14 JP JP2022568692A patent/JP2023528207A/ja active Pending
- 2021-05-14 WO PCT/EP2021/062874 patent/WO2021229076A1/en not_active Ceased
- 2021-05-14 US US17/925,138 patent/US20240279309A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518596A5 (enExample) | ||
| JP2023524054A5 (enExample) | ||
| Chorev | The partial retro–inverso modification: A road traveled together | |
| JP2014508510A5 (enExample) | ||
| JP2020503262A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| JP2012525844A5 (enExample) | ||
| JP2023554379A5 (enExample) | ||
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| JP2023553697A5 (enExample) | ||
| JP2012507271A5 (enExample) | ||
| JP2019506166A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| JP2020528743A5 (enExample) | ||
| JP2010534486A5 (enExample) | ||
| JP2023538422A5 (enExample) | ||
| JP2018528237A5 (enExample) | ||
| JP2018538356A5 (enExample) | ||
| JP2019531093A5 (enExample) | ||
| JP2019530441A5 (enExample) | ||
| CN105693860B (zh) | 特异性靶向her2蛋白的多肽及其应用 | |
| JP2024508683A5 (enExample) | ||
| US20100028353A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| JP2014534807A (ja) | クロスプレゼンテーションを行う樹状細胞を標的としたワクチボディ | |
| JP2025521082A5 (enExample) | ||
| JP2020535811A5 (enExample) |